Ophthalmos Research and Educational Institute

Publication : Omega-3 Fatty Acids Supplementation: Therapeutic Potential in a Mouse Model of Stargardt Disease . IOVS June 2018

Ophthalmos Research team has discovered a novel therapy for vision improvement in patients with Stargardt disease. It is one of the most common forms of macular dystrophy and to date no treatment has provided evidence of disease regression. The published paper shows how fatty acids reduced the accumulation of lipofuscin granules and A2E levels and decreased C3 level, in the retina of animal model of Stargardt disease. It also demonstrated a protective effect against photoreceptors which confirms Ophthalmos Institute observational studies for vision improvement in patients with Stargardt disease.

Link : click HERE for the publication

Ophthalmos Research and Educational Institute
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.